Calregulin shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemCalregulin shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-29234-SH
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Namecalreticulin
NCBI Gene AliasesCALR1, CRT, HEL-S-99n, RO, SSA, cC1qR
Quantity20 µg

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Calreticulin Regulates SARS-CoV-2 Spike Protein Turnover and Modulates SARS-CoV-2 InfectivityCellsNovember 23, 2023Rahimi N, White MR, Amraei R, Lotfollahzadeh S, Xia C, Michalak M, Costello CE, Mühlberger E.with C-terminus C9 tag (#145031) were purchased from Addgene (Watertown, MA, USA). Human CALR-shRNA (#sc-29234-SH) and anti-CALR antibody (#sc-166837) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA).

(2) SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXRActa pharmaceutica Sinica. BFebruary 1, 2023Cui S, Hu H, Chen A, Cui M, Pan X, Zhang P, Wang G, Wang H, Hao H.

(3) Calreticulin Expression Controls Cellular Redox, Stemness, and Radiosensitivity to Function as a Novel Adjuvant for Radiotherapy in NeuroblastomaOxidative medicine and cellular longevityJanuary 1, 2023Chen CJ, Hu YC, Chien Y, Huang WC, Wu CS, Tsai CY, Lin YH, Lee MS, Chien CS, Yang YP, et al.

(4) Calreticulin regulates vascular endothelial growth factor-A mRNA stability in gastric cancer cellsPloS oneJanuary 1, 2019Lee PC, Chiang JC, Chen CY, Chien YC, Chen WM, Huang CW, Weng WC, Chen CI, Lee PH, Chen CN, et al.

(5) LPA_1/3 signaling mediates tumor lymphangiogenesis through promoting CRT expression in prostate cancerBiochimica et biophysica acta. Molecular and cell biology of lipidsOctober 1, 2018Lin YC, Chen CC, Chen WM, Lu KY, Shen TL, Jou YC, Shen CH, Ohbayashi N, Kanaho Y, Huang YL, et al.

(6) BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanomaOncotargetSeptember 19, 2017Liu F, Jiang CC, Yan XG, Tseng HY, Wang CY, Zhang YY, Yari H, La T, Farrelly M, Guo ST, et al.

Be the First to Write a Review!